Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US10105395B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2017 |
| Grant date | Oct 23, 2018 |
| Priority date | — |
| Expiry date | Jun 12, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.